Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients

Định dạng: PDF / Số trang: 12

Nhắn tin với admin nếu không tải được